Dose Finding Study of Single Dose GHB11L1 in Healthy Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Influenza, Human

Interventions

BIOLOGICAL

GHB11L1

GHB11L1 administration by liquid nasal spray at doses of 6.0 log10, 6.5 log10 and 7.0 log10 TCID50/volunteer

BIOLOGICAL

Placebo

SPGN buffer

Trial Locations (1)

Medical University Vienna, Department of Clinical Pharmacology, Vienna